Pin1 contribution to Alzheimer's disease: Transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 207-211

  Arosio, B ^a   Bulbarelli, A ^b   Bastias Candia, S ^c   Lonati, E ^b   Mastronardi, L ^a   Romualdi, P ^c   Candeletti, S ^c   Gussago, C ^a   Galimberti, D ^a   Scarpini, E ^a   Dell'Osso, B ^a   Altamura, C ^a   MacCarrone, M ^d,e   Bergamaschini, L ^a   D'Addario, C ^d   Mari, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF TERAMO   (Italy)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Alzheimer's disease; Epigenetic mechanisms; Phosphorylation mechanisms; Pin1

Indexed keywords

APOLIPOPROTEIN E; PEPTIDYLPROLYL ISOMERASE PIN1; SERINE;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; EPIGENESIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LEUKOCYTES, MONONUCLEAR; MALE; METHYLATION; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SERINE;

EID: 84860214307     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000333799     Document Type: Article

References (29)

1. Holscher C: Development of beta-amyloidinduced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Rev Neurosci 2005; 16: 181-212.
2. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR: Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000; 33: 95-130.
3. Liou YC, Sun A, Ryo A, Zhou XZ, Yu ZX, Huang HK, et al: Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003; 424: 556-561.
4. Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, et al: The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006; 440: 528-534.
5. Rudrabhatla P, Pant HC: Phosphorylationspecific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration. J Alzheimers Dis 2010; 19: 389-403.
6. Segat L, Pontillo A, Annoni G, Trabattoni D, Vergani C, Clerici M, et al: PIN1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol Aging 2007; 28: 69-74.
7. Lu KP, Liou YC, Zhou XZ: Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 2002; 12: 164-172.
8. Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP: Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem 2002; 277: 2381-2384.
9. Bulbarelli A, Lonati E, Cazzaniga E, Gregori M, Masserini M: Pin1 affects Tau phosphorylation in response to Abeta oligomers. Mol Cell Neurosci 2009; 42: 75-80.
10. Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, et al: Pin1 in Alzheimer's disease. J Neurochem 2006; 98: 1697-1706.
11. Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, et al: Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 2006; 22: 223-232.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
13. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDSADRDA criteria. Lancet Neurol 2007; 6: 734-746.
14. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, et al: Interleukin- 10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 2004; 25: 1009-1015.
16. Arosio B, Viazzoli C, Mastronardi L, Bilotta C, Vergani C, Bergamaschini L: Adenosine A 2A receptor expression in peripheral blood mononuclear cells of patients with mild cognitive impairment. J Alzheimers Dis 2010; 20: 991-996.
17. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
18. Janowski B, Wollner S, Schutkowski M, Fischer G: A protease-free assay for peptidyl prolyl cis/trans isomerases using standard peptide substrates. Anal Biochem 1997; 252: 299-307.
19. Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, Grabley S, et al: Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 1998; 37: 5953-5960.
20. Lu KP, Finn G, Lee TH, Nicholson LK: Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol 2007; 3: 619-629.
21. Wang S, Simon BP, Bennett DA, Schneider JA, Malter JS, Wang DS: The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis 2007; 11: 13-23.
22. Ray S, Britschgi M, Herbert C, Takeda- Uchimura Y, Boxer A, Blennow K, et al: Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13: 1359-1362.
23. Gavin DP, Sharma RP: Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev 2010; 34: 882-888.
24. Maruszak A, Safranow K, Gustaw K, Kijanowska- Haladyna B, Jakubowska K, Olszewska M, et al: PIN1 gene variants in Alzheimer's disease. BMC Med Genet 2009; 10: 115-126.
25. Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A, et al: Elevation of3β 42-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. Arch Neurol 2010; 67: 867-872.
26. Hall EC 2nd, Lee SY, Simmons Z, Neely EB, Nandar W, Connor JR: Prolyl-peptidyl isomerase, Pin1, phosphorylation is compromised in association with the expression of the HFE polymorphic allele, H63D. Biochim Biophys Acta 2010; 1802: 389-395.
27. Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, et al: Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 2004; 24: 2527-2534.
28. Bu G: Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009; 10: 333-344.
29. Lonati B, Masserini M, Bulbarelli A: Pin1: a new outlook in Alzheimer disease. Curr Alzheimer Res, E-pub ahead of print.